FE65 Interaction with the ApoE Receptor ApoEr2
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The adaptor protein FE65 interacts with the beta-amyloid precursor protein (APP) via its C-terminal phosphotyrosine binding (PTB) domain and affects APP processing and Abeta production. Our previous data demonstrate that the apoE receptor ApoEr2 co-precipitated with APP and suggest that there are extracellular and intracellular interactions between these two transmembrane proteins. We hypothesized that FE65 acts as an intracellular link between ApoEr2 and APP. Co-immunoprecipitation experiments in COS7 cells demonstrated an interaction between ApoEr2 and FE65 that depended on the N-terminal PTB domain of FE65. Full-length FE65 increased co-immunoprecipitation of ApoEr2 and APP. Full-length FE65 also increased surface expression of ApoEr2, as determined by surface protein biotinylation and live cell surface staining. Constructs containing both the C- and N-terminal PTB domains of FE65 increased secreted APP, secreted ApoEr2, APP C-terminal fragment, and ApoEr2 C-terminal fragment, but constructs containing only single PTB domains did not affect APP or ApoEr2 processing. In addition, full-length FE65 decreased Abeta to a significantly greater extent than individual FE65 domains. These data suggest that FE65 can bind APP and ApoEr2 at the same time and affect the processing of each.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, Dab1 overexpression increases the surface levels of ApoER2 and APP, along with an increase in the processing of both proteins [54].”
From Sorting nexin 17 regulates ApoER2 recycling and reelin signaling (2014) · cites this paper as [54]
In the citing paper
“Interestingly, some of these proteins also regulate the proteolytic processing of this receptor [42], [54], [55], [66] by binding to its NPxY motif.”
From Sorting nexin 17 regulates ApoER2 recycling and reelin signaling (2014) · cites this paper as [54]
In the citing paper
“When over expressing adaptor proteins, which are associated with higher levels of receptor at the cell surface, the ApoER2 CTF (the product of sheddases and substrate of the γ-secretase complex) is also detected at a higher level [40], [54].”
From Sorting nexin 17 regulates ApoER2 recycling and reelin signaling (2014) · cites this paper as [54]
In the citing paper
“intracellular interactions with Fe65 (middle panel) (72)”
From Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses (2017) · cites this paper as [72]
In the citing paper
“ApoER2 binds a second PTB domain of Fe65 (via the NPXY domain, white circle) (72)”
From Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses (2017) · cites this paper as [72]
Citations
Cites
LRP: a multifunctional scavenger and signaling receptor
Herz, J., & Strickland, D. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13992 · Cited by 908
LRP: a multifunctional scavenger and signaling receptor
Herz, J., & Strickland, D. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113992 · Cited by 908
Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning
Weeber, E. J., Beffert, U., Jones, C., Christian, J. M., Förster, E., Sweatt, J. D., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205147200 · Cited by 623
Borg, J.-P., Ooi, J., Levy, E., & Margolis, B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6229 · Cited by 477
Trommsdorff, M., Borg, J.-P., Margolis, B., & Herz, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33556 · Cited by 453
Gotthardt, M., Trommsdorff, M., Nevitt, M. F., Shelton, J., Richardson, J. A., Stockinger, W., Nimpf, J., & Herz, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000955200 · Cited by 450
Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., Hyman, B. T., & Strickland, D. K. (1995) · Cell · doi:10.1016/0092-8674(95)90320-8 · Cited by 401
Self-citationWang, P., Yang, G., Mosier, D. R., Chang, P., Zaidi, T., Gong, Y.-D., Zhao, N.-M., Dominguez, B., Lee, K.-F., Gan, W.-B., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4660-04.2005 · Cited by 290
Ulery, P. G., Beers, J., Mikhailenko, I., Tanzi, R. E., Rebeck, G. W., Hyman, B. T., & Strickland, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7410 · Cited by 271
Self-citationAndo, K., Iijima, K.-I., Elliott, J. I., Kirino, Y., & Suzuki, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104059200 · Cited by 261
Cited by
Substrate specificity of γ-secretase and other intramembrane proteases
Beel, A. J., & Sanders, C. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7462-2 · Cited by 269
DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing
Hoe, H.-S., Tran, T. S., Matsuoka, Y., Howell, B. W., & Rebeck, G. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602162200 · Cited by 174
Self-citationThe FE65 proteins and Alzheimer's disease
McLoughlin, D. M., & Miller, C. C. J. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21532 · Cited by 138
Lipoprotein receptors – an evolutionarily ancient multifunctional receptor family
Dieckmann, M., Dietrich, M. F., & Herz, J. (2010) · Biological Chemistry · doi:10.1515/bc.2010.129 · Cited by 127
Marzolo, M.-P., & Bu, G. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.10.005 · Cited by 122
Sorting receptor SORLA – a trafficking path to avoid Alzheimer disease
Willnow, T. E., & Andersen, O. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.125393 · Cited by 121
“1B) (Cam et al., 2004; Cam et al., 2005; Hoe et al., 2005; Hoe et al., 2006).”
BackgroundReelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses
Wasser, C. R., & Herz, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.766782 · Cited by 111
“Fe65 (via the NPXY domain, white circle) (72) or the PDZ domains of X11 / via”
BackgroundPresenilin-dependent regulated intramembrane proteolysis and γ-secretase activity
McCarthy, J. V., Twomey, C., & Wujek, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8435-9 · Cited by 139
Functional Roles of the Interaction of APP and Lipoprotein Receptors
Pohlkamp, T., Wasser, C. R., & Herz, J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00054 · Cited by 92
“Dab1 also binds the NPxY motifs of Apoer2 and APP, and Aβ is decreased with Dab1 overexpression and increased in Dab1-deficient primary neurons (Hoe et al., 2006c).”
BackgroundInfluentialAge-related accumulation of Reelin in amyloid-like deposits
Knuesel, I., Nyffeler, M., Mormède, C., Muhia, M., Meyer, U., Pietropaolo, S., Yee, B. K., Pryce, C. R., LaFerla, F. M., Marighetto, A., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.011 · Cited by 94
The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease
Lane-Donovan, C., & Herz, J. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075507 · Cited by 94
“Similarly, Fe65 interacts intracellularly with both APP and Apoer2 to form a trimeric complex (62).”
BackgroundSimilarities and differences in structure, expression, and functions of VLDLR and ApoER2
Reddy, S. S., Connor, T. E., Weeber, E. J., & Rebeck, W. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-30 · Cited by 93
The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor
Dlugosz, P., & Nimpf, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103090 · Cited by 91
“VLDLR has common intracellular interacting partners with ApoER2 (Figure 4), like Dab1 or FE65 [104].”
BackgroundHoe, H.-S., Cooper, M. J., Burns, M. P., Lewis, P. A., van der Brug, M., Chakraborty, G., Cartagena, C. M., Pak, D. T. S., Cookson, M. R., & Rebeck, G. W. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3135-07.2007 · Cited by 90
Self-citationTang, B. L. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.1.7254 · Cited by 83
Wolfe, M. S., & Guénette, S. Y. (2007) · Journal of Cell Science · doi:10.1242/jcs.03481 · Cited by 96
Santana, J., & Marzolo, M. (2017) · Biochemical Journal · doi:10.1042/bcj20160628 · Cited by 79
Fuentealba, R. A., Barría, M. I., Lee, J., Cam, J., Araya, C., Escudero, C. A., Inestrosa, N. C., Bronfman, F. C., Bu, G., & Marzolo, M.-P. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-14 · Cited by 70
LRP8 mediates Wnt/β-catenin signaling and controls osteoblast differentiation
Zhang, J., Zhang, X., Zhang, L., Zhou, F., van Dinther, M., & ten Dijke, P. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1661 · Cited by 77
The generation and function of soluble apoE receptors in the CNS
Rebeck, G. W., LaDu, M. J., Estus, S., Bu, G., & Weeber, E. J. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-15 · Cited by 66
Self-citationNovel modulators of amyloid‐β precursor protein processing
Tang, B. L., & Liou, Y. C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04215.x · Cited by 57
Minopoli, G., Stante, M., Napolitano, F., Telese, F., Aloia, L., De Felice, M., Di Lauro, R., Pacelli, R., Brunetti, A., Zambrano, N., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c600276200 · Cited by 56
Fyn Modulation of Dab1 Effects on Amyloid Precursor Protein and ApoE Receptor 2 Processing
Hoe, H.-S., Minami, S. S., Makarova, A., Lee, J., Hyman, B. T., Matsuoka, Y., & Rebeck, G. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704140200 · Cited by 49
Self-citationSorting nexin 17 regulates ApoER2 recycling and reelin signaling
Sotelo, P., Farfán, P., Benitez, M. L., Bu, G., & Marzolo, M.-P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093672 · Cited by 47
“HA-ApoER2- and HA-ApoER2-NPxAexpressing N2a cells [24,54] were maintained in growth medium supplemented with 400 mg/mL G418.”
BackgroundMethodInfluentialPlatelets express three different splice variants of ApoER2 that are all involved in signaling
Pennings, M. T. T., Derksen, R. H. W. M., Urbanus, R. T., Tekelenburg, W. L. H., Hemrika, W., & de Groot, P. G. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02605.x · Cited by 46
Structural Basis for Polyproline Recognition by the FE65 WW Domain
Muthuraman, M., Birrane, G., & Ladias, J. A. A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.064 · Cited by 48
Hoareau, C., Borrell, V., Soriano, E., Krebs, M., Prochiantz, A., & Allinquant, B. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.012 · Cited by 42
Reelin Signaling in Neurodevelopmental Disorders and Neurodegenerative Diseases
Joly‐Amado, A., Kulkarni, N., & Nash, K. R. (2023) · Brain Sciences · doi:10.3390/brainsci13101479 · Cited by 50
Functional interactions of APP with the apoE receptor family
Hoe, H., & William Rebeck, G. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05517.x · Cited by 41
Self-citationReelin in Alzheimer’s Disease, Increased Levels but Impaired Signaling: When More is Less
Cuchillo‐Ibáñez, I., Balmaceda, V., Mata‐Balaguer, T., López‐Font, I., & Sáez‐Valero, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151193 · Cited by 37
FE65 interacts with ADP-ribosylation factor 6 to promote neurite outgrowth
Cheung, H. N. M., Dunbar, C., Mórotz, G. M., Cheng, W. H., Chan, H. Y. E., Miller, C. C. J., & Lau, K. (2014) · The FASEB Journal · doi:10.1096/fj.13-232694 · Cited by 37
FE65 as a link between VLDLR and APP to regulate their trafficking and processing
Dumanis, S. B., Chamberlain, K. A., Jin Sohn, Y., Jin Lee, Y., Guénette, S. Y., Suzuki, T., Mathews, P. M., Pak, D. T., Rebeck, G. W., Suh, Y.-H., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-9 · Cited by 34
Self-citationNensa, F. M., Neumann, M. H., Schrötter, A., Przyborski, A., Mastalski, T., Susdalzew, S., Looβe, C., Helling, S., Magraoui, F. E., Erdmann, R., et al. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.029280 · Cited by 40
The role of lipoprotein receptors on the physiological function of APP
Wagner, T., & Pietrzik, C. U. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2876-8 · Cited by 32
Minami, S. S., Sung, Y. M., Dumanis, S. B., Chi, S. H., Burns, M. P., Ann, E.-J., Suzuki, T., Turner, R. S., Park, H.-S., Pak, D. T. S., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-138123 · Cited by 28
“Immunoprecipitations were conducted with relevant antibodies as described previously (7, 8).”
MethodSelf-citationBórquez, D. A., & González-Billault, C. E. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/353145 · Cited by 32
Fe65 Stimulates Proteolytic Liberation of the β-Amyloid Precursor Protein Intracellular Domain
Wiley, J. C., Smith, E. A., Hudson, M. P., Ladiges, W., & Bothwell, M. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706024200 · Cited by 28
Wang, Y., Zhang, M., Moon, C., Hu, Q., Wang, B., Martin, G., Sun, Z., & Wang, H. (2009) · Learning & Memory · doi:10.1101/lm.1499309 · Cited by 28
Sun, Y., Sun, J., Lungchukiet, P., Quarni, W., Yang, S., Zhang, X. M., & Bai, W. (2015) · Scientific Reports · doi:10.1038/srep11529 · Cited by 31
Chow, W. N. V., Ngo, J. C. K., Li, W., Chen, Y. W., Tam, K. M. V., Chan, H. Y. E., Miller, C. C. J., & Lau, K.-F. (2015) · Biochemical Journal · doi:10.1042/bj20141485 · Cited by 26
Minami, S., Hoe, H., & Rebeck, G. W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07296.x · Cited by 27
Self-citationLigand-induced Homotypic and Heterotypic Clustering of Apolipoprotein E Receptor 2
Divekar, S. D., Burrell, T. C., Lee, J. E., Weeber, E. J., & Rebeck, G. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537548 · Cited by 25
Self-citationStrecker, P., Ludewig, S., Rust, M. B., Mundinger, T. A., Görlich, A., Krächan, E. G., Mehrfeld, C., Herz, J., Körte, M., Guénette, S. Y., et al. (2016) · Scientific Reports · doi:10.1038/srep25652 · Cited by 23
Regulated Proteolysis of APP and ApoE Receptors
Hoe, H., & Rebeck, G. W. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8017-0 · Cited by 24
Self-citationChan, W. W. R., Li, W., Chang, R. C. C., & Lau, K. (2020) · The FASEB Journal · doi:10.1096/fj.202001703r · Cited by 20
Dab1 binds to Fe65 and diminishes the effect of Fe65 or LRP1 on APP processing
Kwon, O. Y., Hwang, K., Kim, J., Kim, K., Kwon, I. C., Song, H. K., & Jeon, H. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22738 · Cited by 18
Phosphorylation of FE65 at threonine 579 by GSK3β stimulates amyloid precursor protein processing
Lee, Y. S., Chow, W. N. V., & Lau, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-12334-2 · Cited by 18
Fe65: A Scaffolding Protein of Actin Regulators
Augustin, V., & Kins, S. (2021) · Cells · doi:10.3390/cells10071599 · Cited by 20
Crystal Structure of the Human Fe65-PTB1 Domain
Radzimanowski, J., Ravaud, S., Schlesinger, S., Koch, J., Beyreuther, K. T., Sinning, I., & Wild, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800861200 · Cited by 19
Probst, S., Krüger, M., Kägi, L., Thöni, S., Schuppli, D., Nitsch, R. M., & Konietzko, U. (2020) · Journal of Cell Science · doi:10.1242/jcs.242917 · Cited by 19
Stx5 is a novel interactor of VLDL-R to affect its intracellular trafficking and processing
Wagner, T., Dieckmann, M., Jaeger, S., Weggen, S., & Pietrzik, C. U. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.05.010 · Cited by 13
Human APOER2 Isoforms Have Differential Cleavage Events and Synaptic Properties
Omuro, K. C., Gallo, C. M., Scrandis, L., Ho, A., & Beffert, U. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1800-21.2022 · Cited by 10
A Novel Function of the Fe65 Neuronal Adaptor in Estrogen Receptor Action in Breast Cancer Cells
Sun, Y., Kasiappan, R., Tang, J., Webb, P. L., Quarni, W., Zhang, X. M., & Bai, W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.526194 · Cited by 11
Apolipoprotein E receptor pathways in Alzheimer disease
Schmidt, V., Carlo, A.-S., & Willnow, T. E. (2014) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1262 · Cited by 11
Larios, J. A., & Marzolo, M.-P. (2012) · Frontiers in Biology · doi:10.1007/s11515-011-1186-7 · Cited by 9
Nam, Y., Joo, B., Lee, J., Han, K., Ryu, K., Koh, Y. H., Kim, J., Koo, J. W., We, Y.-M., & Hoe, H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00192 · Cited by 12
Self-citationMulvihill, M. M., Guttman, M., & Komives, E. A. (2011) · Biochemistry · doi:10.1021/bi200508f · Cited by 9
Radzimanowski, J., Beyreuther, K. T., Sinning, I., & Wild, K. (2008) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309108009524 · Cited by 8
Suh, J., Moncaster, J. A., Wang, L., Hafeez, I., Herz, J., Tanzi, R. E., Goldstein, L. E., & Guénette, S. Y. (2015) · The FASEB Journal · doi:10.1096/fj.14-261453 · Cited by 9
Mercury-induced crystallization and SAD phasing of the human Fe65-PTB1 domain
Radzimanowski, J., Ravaud, S., Beyreuther, K. T., Sinning, I., & Wild, K. (2008) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s174430910800835x · Cited by 3
The Amyloid β Precursor Protein and Cognitive Function in Alzheimer’s Disease
Marr, R. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00004-8 · Cited by 3
Morelli, L., Perry, G. L., & Tagliavini, F. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/709613 · Cited by 3
Ravikumar, G., Vasantkumar, V. K., Bala, R., Modala, V., Rao, G., & Kumar, V. (2014) · Journal of Molecular Recognition · doi:10.1002/jmr.2350 · Cited by 1
TRAFFICKING OF ALPHA SECRETASE ADAM10: NEW INSIGHTS INTO THE MOLECULAR MECHANISM OF MODULATION
Saraceno, C. (2012) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/saraceno-claudia_phd2012-02-08
In vitro and in vivo characterization of the E3 ubiquitin ligase RNF157 in the brain
Lee, S.-J. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5029
Engert, J., Doll, J., Vona, B., Kasemo, T. E., Spahn, B., Hagen, R., Rak, K., & Voelker, J. (2023) · Life · doi:10.3390/life13091858
APP family is a regulator of endo-lysosomal membrane vulnerability
Lundin, B., Wieckiewicz, N., Yokomizo, M., Sadek, M., Kwarteng, D. O., Dickson, J. R., Sobolewski, R. G. R., Derosla, V., Armagan, G., Perrin, F., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110774 · Cited by 1
Cohen, R. (2018) · theses.fr (ABES) · doi:10.70675/759ed785ze142z4504za8abzd5cf222c1a59
Metadata
- Authors
- Hoe, H.-S., Magill, L. A., Guenette, S., Fu, Z., Vicini, S., & Rebeck, G. W.
- Affiliations
- Georgetown University Medical Center (US)
- Corresponding author
- Rebeck, G. William
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 281
- Issue
- 34
- Pages
- 24521-24530
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1991811507
- Cited by
- 69
- References
- 36
- Citations by year
- 2025: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 4 · 2012: 6
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5203 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG14473)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Fe65, APP processing, amyloid-beta production, phosphotyrosine binding domain, protein-protein interaction, APP C-terminal fragments, cell surface expression, Alzheimer's disease
- MeSH terms
- Animals, Binding Sites, Cells, Cultured, Humans, Nerve Tissue Proteins, Neurons, Nuclear Proteins, Protein Binding, Amyloid beta-Protein Precursor, Protein Structure, Tertiary, Receptors, Lipoprotein, Protein Transport, LDL-Receptor Related Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.